Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
other
- Another substantial sale-and-lease-back transaction closed - Sales of 3 care and 3 rehabilitation facilities with a total real estate value of EUR 95.5 million - Rehabilitation segment increases inner reserve

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

29.06.2007

Berlin, June 29, 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) successfully closed a third substantial sale-and-lease-back transaction with real estate investor Grosvenor House Group PLC, Great Britain. To this end, Marseille-Kliniken AG will sell a total of six properties - three care facilities and three rehabilitation properties, totalling 1,304 beds to the British investor by way of a sale-and-lease-back transaction and will simultaneously lease all properties back from the company in the long term.

The transaction with a total volume of EUR 95.5 million provides the enterprise with expanded financial flexibility to realize its growth strategy in core segment care. It must be emphasized that the largest share in the transaction, more than 60%, comes from the rehabilitation segment. The sales revenues generated from the rehabilitation segment thus accounts for more than 90% of the balance sheet book value of the entire rehabilitation segment, marking the first increase of inner reserves in this sector.

After the implementation of the transaction, the real estate portfolio of the Marseille-Kliniken AG will be divided into approximately 20% owned and 80% leased facilities. The transaction will further reduce the long term financial debts of the enterprise.

End of adhoc release

@@start.t2@@end of announcement                                                 euro adhoc 29.06.2007 07:27:47
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
If you have any questions, please contact:
Marseille-Kliniken AG
Axel Hölzer
CEO
Alte Jakobstraße 79/80
10709 Berlin, Germany
Tel.: +49-30 / 246 32-400
Fax:  +49-30 / 246 32-401
www.marseille-kliniken.com

or

Hillermann Consulting
Christian Hillermann
Investor Relations Marseille-Kliniken AG
Eppendorfer Baum 5
20249 Hamburg
Germany
Tel.: +49-40 / 414 069-13
Fax:  +49-40 / 414 069-14
www.hillermann-consulting.com

Branche: Pharmaceuticals
ISIN:      DE0007783003
WKN:        778300
Index:    CDAX, Classic All Share, Prime All Share
Börsen:  Börse Frankfurt / official dealing/prime standard
              Börse Berlin / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hamburg / official dealing



Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: